Naringenin modulates the metastasis of human prostate cancer cells by down regulating the matrix metalloproteinases -2/-9 via ROS/ERK1/2 pathways
Metastasis is a multifactorial condition that complicates cancer treatment options and widens the target of treatment. Matrix mettalopriteinases (MMPs) of the extracellular matrix (ECM) are involved in metastasis, thus they present as potential targets in halting cancer metastasis. The study was un...
Main Authors: | Er-Jiang Lin, Xian Zhang, Da-Ya Wang, Shi-Zhe Hong, Lei-Yu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Bangladesh Pharmacological Society
2014-09-01
|
Series: | Bangladesh Journal of Pharmacology |
Subjects: | |
Online Access: | https://www.banglajol.info/index.php/BJP/article/view/19730 |
Similar Items
-
Naringenin regulates production of matrix metalloproteinases in the knee-joint and primary cultured articular chondrocytes and alleviates pain in rat osteoarthritis model
by: C.C. Wang, et al. -
Thrombospondin-2 promotes prostate cancer bone metastasis by the up-regulation of matrix metalloproteinase-2 through down-regulating miR-376c expression
by: Po-Chun Chen, et al.
Published: (2017-01-01) -
Targeting Some Key Metalloproteinases by Nano-Naringenin and <i>Amphora coffeaeformis</i> as a Novel Strategy for Treatment of Osteoarthritis in Rats
by: Nema S. Shaban, et al.
Published: (2023-02-01) -
Matrix metalloproteinases in the process of invasion and metastasis of breast cancer
by: Konjević Gordana, et al.
Published: (2006-01-01) -
Naringenin Induces HepG2 Cell Apoptosis via ROS-Mediated JAK-2/STAT-3 Signaling Pathways
by: Ming Zhang, et al.
Published: (2023-06-01)